We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+12.21%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$53.1B
AUM Growth
+$4.7B
(+9.7%)
Cap. Flow
-$415M
Cap. Flow
% of AUM
-0.78%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
2,495
New
186
Increased
937
Reduced
1,188
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$144M |
| 2 |
NVIDIA
NVDA
|
+$137M |
| 3 |
GE Aerospace
GE
|
+$129M |
| 4 |
Dell
DELL
|
+$91.3M |
| 5 |
Comcast
CMCSA
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$103M |
| 2 |
Microchip Technology
MCHP
|
+$98.3M |
| 3 |
Steel Dynamics
STLD
|
+$87M |
| 4 |
UnitedHealth
UNH
|
+$79.5M |
| 5 |
Walmart Inc
WMT
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.58% |
| 2 | Consumer Discretionary | 13.58% |
| 3 | Healthcare | 12.97% |
| 4 | Financials | 12.15% |
| 5 | Industrials | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Acadia Pharmaceuticals
ACAD
$5.07B
| $1.54M | ﹤0.01% |
49,247
+1,120
| +2% | +$26.7K |
|
1452
Evolv Technologies
EVLV
$1.08B
| $1.54M | ﹤0.01% |
325,786
+274,226
| +532% | +$1.17M |
|
1453
Dillards
DDS
$10.1B
| $1.53M | ﹤0.01% |
3,801
-2,509
| -40% | -$851K |
|
1454
Target Hospitality
TH
$1.66B
| $1.53M | ﹤0.01% |
157,580
-14,350
| -8% | -$177K |
|
|
SPYM
1455
State Street SPDR Portfolio S&P 500 ETF
SPYM
$168B
| $1.53M | ﹤0.01% |
27,380
+4,501
| +20% | +$236K |
|
1456
Hims & Hers Health
HIMS
$7.06B
| $1.53M | ﹤0.01% |
171,520
+21,882
| +15% | +$162K |
|
|
ONTF
1457
DELISTED
ON24
ONTF
| $1.52M | ﹤0.01% |
192,468
+8,736
| +5% | +$60.6K |
|
1458
Itaú Unibanco
ITUB
$82.7B
| $1.51M | ﹤0.01% |
246,026
-95,775
| -28% | -$508K |
|
1459
Terreno Realty
TRNO
$7.44B
| $1.5M | ﹤0.01% |
24,011
+6,281
| +35% | +$357K |
|
1460
Atara Biotherapeutics
ATRA
$80.6M
| $1.5M | ﹤0.01% |
117,292
+83,514
| +247% | +$1.95M |
|
|
AEL
1461
DELISTED
American Equity Investment Life Holding Company
AEL
| $1.5M | ﹤0.01% |
26,926
+3,315
| +14% | +$180K |
|
|
ZUO
1462
DELISTED
Zuora, Inc.
ZUO
| $1.5M | ﹤0.01% |
159,175
-25,011
| -14% | -$206K |
|
1463
AMC Entertainment Holdings
AMC
$2.14B
| $1.49M | ﹤0.01% |
244,264
-13,182
| -5% | -$107K |
|
1464
Waters Corp
WAT
$40.7B
| $1.49M | ﹤0.01% |
4,530
-18,229
| -80% | -$5.03M |
|
|
SGI
1465
Somnigroup International
SGI
$13.7B
| $1.49M | ﹤0.01% |
29,180
-4,822
| -14% | -$205K |
|
1466
Stewart Information Services
STC
$2B
| $1.48M | ﹤0.01% |
25,234
-26,063
| -51% | -$1.24M |
|
1467
Veracyte
VCYT
$3.73B
| $1.48M | ﹤0.01% |
53,839
-14,596
| -21% | -$352K |
|
1468
La-Z-Boy
LZB
$1.66B
| $1.47M | ﹤0.01% |
39,842
-22,625
| -36% | -$729K |
|
|
PLYA
1469
DELISTED
Playa Hotels & Resorts
PLYA
| $1.47M | ﹤0.01% |
169,649
-10,530
| -6% | -$79.3K |
|
|
BRT
1470
BRT Apartments
BRT
$266M
| $1.47M | ﹤0.01% |
78,855
-37,648
| -32% | -$666K |
|
1471
Liberty Global Class C
LBTYK
$3.4B
| $1.47M | ﹤0.01% |
79,127
-96,650
| -55% | -$1.67M |
|
1472
Hyatt Hotels
H
$16.3B
| $1.46M | ﹤0.01% |
11,222
-9,595
| -46% | -$1.09M |
|
1473
RXO
RXO
$3.54B
| $1.46M | ﹤0.01% |
62,841
-794,650
| -93% | -$16M |
|
|
SAGE
1474
DELISTED
Sage Therapeutics
SAGE
| $1.45M | ﹤0.01% |
67,042
-7,141
| -10% | -$142K |
|
1475
EQT Corp
EQT
$34B
| $1.45M | ﹤0.01% |
37,562
-23,701
| -39% | -$961K |
|
Similar funds
VGA
AQR Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, AQR Capital Management held 2,495 positions worth $53.1B, up 9.7% from $48.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management's Q4 2023 filing shows 186 new, 937 increased, 1,188 reduced and 172 closed positions. Its largest new stake was NCR Atleos: 518,383 shares worth $12.5M. The largest sale was Pfizer, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q4 2023 buy was NCR Atleos: 518,383 shares worth $12.5M.
- AQR Capital Management added most to Amazon in Q4 2023, an estimated $144M increase.
- AQR Capital Management's biggest Q4 2023 reduction was Pfizer, cutting an estimated $103M.
- AQR Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $38.5M.
- AQR Capital Management's ten largest holdings make up 15% of its $53.1B portfolio in Q4 2023.
- AQR Capital Management opened 186 new positions and closed 172 in Q4 2023.
- AQR Capital Management's portfolio value rose 9.7% quarter-over-quarter to $53.1B.
Based on AQR Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.